Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed, indicating an updated revision state for the study record.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision. This change does not affect the visible content or functionality.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page updates include adding Dr Krisztian Homicsko's name and adding help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with updating the revision to v3.6.0. It also removes the previous Last known status detail and the affiliation from the header and adjusts the Intervention/Treatment label.SummaryDifference2%

- Check29 days agoChange DetectedThe study record's revision block was updated to v3.5.5 with the updater's details (Dr Krisztian Homicsko, 2023-02) and status verification, replacing the previous revision v3.5.4.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor post-publication update to the study record. This update appears to be administrative and does not reflect substantive changes to the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.